Αναρτήσεις

Εμφάνιση αναρτήσεων με την ετικέτα cancer

Glutamine Metabolism in Cancer Treatment

Εικόνα
 Glutamine Metabolism in Cancer Treatment Glucose and the amino acid glutamine are the two most important nutrients used by cancer cells for their proliferation and growth. While the glycolonic pathway produces ATP and metabolic intermediates, the metabolism of glutamine can provide amino acids, nucleic acids and glutathione necessary for cell proliferation. Among the various characteristics of cancer, metabolic transformation plays a key role in adapting cancer cells in a changing environment. Cancer cells carry ontigenic mutations, leading to an increase in nutrient uptake and altering their metabolism to support anabolic processes for cell growth and proliferation.

Scientists have discovered a way to destroy cancer tumors using nothing but sound waves

Εικόνα
 Scientists have discovered a way to destroy cancer tumors using nothing but sound waves A recent breakthrough in high-intensity focused ultrasound therapy (HIFU) technology has proven its use as an effective cancer treatment. A multi-institutional research team from China developed a semi-enclosed, spherical cavity transducer that can produce a focused, standing-wave field with a subwavelength-scale focal region and extremely high ultrasound intensity.  The spherical cavity transducer appeared to generate tighter focal regions and greater pressure amplitude compared with the traditional concave spherical transducer. Researchers said the level of intensity generated by the new transducer design may lead to significant improvements in HIFU therapy. The findings were published in the Journal of Applied Physics.

Immunodiagnosis and Immunotherapy: A new Era in Cancer with 25 monoclonal antibodies

Εικόνα
 Immunodiagnosis and Immunotherapy: A new Era in Cancer with 25 monoclonal antibodies The PCS (Pioneer Centrury Science) conference based on China, organized a fantastic conference for cancer with the title: Stimulating Innovation to improve Quality of Life, which was held in Athens, Greece at November 15-16th. The president of the conference was Professor Dr. Chiming Wei, MD, PhD., assistant professor at May Clinic, USA, and director of Nanomedicin research Lab in John Hopkins University  School of Medicine.

What Most Doctors REALLY Think About Alternative Cancer Treatments

Εικόνα
 What Most Doctors REALLY Think About Alternative Cancer Treatments Authored By Ty Bollinger How receptive are most oncologists to using alternative cancer therapies for their patients? Not surprisingly, most medical practitioners are  apprehensive to their patients utilizing cancer treatments that are not considered “standard of care.” But not for the reasons you may think…which will be explained later in this article. Most physicians interviewed in Dr. Ivy Lynn Bourgeault’s (from the Canada Medical Association) research said they opposed the use of alternative cancer therapies for their patients. Yet, according to Dr. Bourgeault, “54% of people with cancer use alternative therapies and up to half of those patients completely abandon standard medical treatments in exchange for alternative methods.”

The Role of Probiotics in Cancer

Εικόνα
Most of us know that probiotics are the friendly bacteria that populate our intestines. Probiotics can help improve digestion and elimination, and protect our gut from invasion by undesirable pathogenic micro-organisms. Probiotics also help the immune system function at full capacity (70% of the immune system lies in the gut). Scientists are now learning how life-saving probiotics can be (the term literally means ‘for life’), especially in the cancer field. They suspect that one of the reasons that susceptibility to cancer of the colon and bladder increases with age is linked to a drop in probiotic levels in the body. Taking high dose probiotic supplements may help fight cancer by:     Detoxifying potential colon carcinogens (J. Dairy Sci. 79:745)     Decreasing recurrence of bladder tumors (Eur. Urol. 27:104)    Eliminating aflatoxin, a common carcinogen found in peanuts (Food Prot. 63:1133)     Enhancing elimination of en...

What is the AMAS test?

Εικόνα
"The second leading cause of death, cancer kills more than half a million people annually, while the cancer drug industry rakes in $100 billion each year while simultaneously causing more cancer. However, this wouldn’t be the case if the cancer treatment industry was more interested in curing and preventing cancer than it is in simply just treating it. The good news is that there are alternatives for preventing and curing cancer, although information on this can be difficult to access, as it’s routinely suppressed by the medical establishment and their paid-for media, who’s not interested in providing “care” unless it’s profitable or generates repeat business. One of the greatest tools in beating cancer is early detection, and no, this does not mean you should include radiological imaging as part of your annual checkup, as that can cause more cancer. However, a little known test called the AMAS test, or the Anti-Malignan Antibody Serum test, is incredibly bene...

Hopeful News for Lung Cancer Treatment

Εικόνα
"A last-chance drug that can lead to an “unprecedented” reduction in lung cancer tumours has become available on the NHS. Tagrisso (osimertinib) was granted a licence only in February and has been hailed as a breakthrough drug by manufacturer AstraZeneca. The once-a-day tablet will be available immediately for patients with non-small-cell lung cancer who have a specific mutation, known as EGFR T790M-positive, that means they have stopped responding to earlier treatments. Experts predict about 300 patients in England and Wales will be eligible for Tagrisso every year. The National Institute for Health and Care Excellence (Nice) has issued final draft guidance that says Tagrisso should be made available through the Cancer Drugs Fund (CDF), after a financial agreement was reached with AstraZeneca. Prof Carole Longson, the director of the health technology evaluation centre at Nice, said the drug was being made available while clinical trials continue to assess its...